Vijaypd Ceutical IPO is a book-built issue aiming to raise ₹19.25 crore. It comprises a fresh issue of 0.55 crore shares. The bidding window was open from September 29, 2025, to October 1, 2025, with the IPO allotment to be finalised on October 3, 2025. Vijaypd Ceutical is scheduled to list on NSE SME on October 7, 2025.
The IPO was priced at ₹35 per share with a lot size of 4,000 shares. The public issue received bids for 71,64,000 shares against 52,16,000 shares available, resulting in an overall subscription of1.37 times. NIIs led the response, subscribing1.86 times their quota, followed by retail investors at 0.89 times.
Vijaypd Ceutical’s ₹19.25 crore IPO, priced at ₹35 per share, was subscribed1.37 times overall. The IPO consists of a fresh issue of 0.55 crore shares of ₹19.25 crore. Bidding took place from September 29 to October 1, 2025, with the Vijaypd Ceutical IPO allotment status on October 3, 2025. Retail investors subscribed 0.89 times and NIIs 1.86 times. Listing is expected on October 7, 2025.
The table below breaks down the Vijaypd Ceutical share allocation for different categories, highlighting the number of shares and their percentage of the total issue. However, the key focus remains on the quotas allocated to retail investors and HNIs, as they are the most relevant for individual investors.
Investor Category | Shares Offered |
Market Maker Shares Offered | 2,84,000 (5.16%) |
NII (HNI) Shares Offered | 26,08,000 (47.42%) |
Retail Shares Offered | 26,08,000 (47.42%) |
Data Source: NSE
Category | Subscription (times) |
Market Maker | 1 |
Non-Institutional Investors | 1.86 |
Retail Individual Investors | 0.89 |
Total shares | 1.37 |
Note: The subscription details are as of October 1, 2025
Vijaypd Ceutical Limited is engaged in the business of distribution and supply within the pharmaceutical and consumer goods sectors, offering a comprehensive range of services. The company operates as a representative, dealer, agent, stockist, supplier, trader, and packer. Its product portfolio serves both the pharmaceutical and wellness industries, as well as the fast-moving consumer goods (FMCG) market.
The company’s pharmaceutical and wellness products include medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral formulations. Additionally, Vijaypd Ceutical supplies vitamins, hormones, enzymes, wellness tonics, serums, and diagnostic test kits. In the FMCG segment, the company provides personal care and toiletry products.
A pharmaceutical supply chain involves multiple stages, from manufacturing to distribution and the delivery of medicines and vaccines to end consumers. This process includes drug distribution, inventory management, pharmaceutical logistics, and overall supply chain management, with participation from manufacturers, suppliers, distributors, logistics partners, shippers, and pharmaceutical retailers.
As a distributor of pharmaceutical products, Vijaypd Ceutical Limited leverages advanced technology to deliver comprehensive healthcare solutions to pharmacies, nursing homes, and clinics across Western Suburban Mumbai, South Mumbai, Ratnagiri, Aurangabad, and Akola. The company operates three distribution warehouses in Mumbai, ensuring timely and efficient deliveries.
Know more about IPO allotment status and check your application details online for the latest updates on share allocation.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Oct 1, 2025, 6:34 PM IST
Neha Dubey
Neha Dubey is a Content Analyst with 3 years of experience in financial journalism, having written for a leading newswire agency and multiple newspapers. At Angel One, she creates daily content on finance and the economy. Neha holds a degree in Economics and a Master’s in Journalism.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates